These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 38078745)

  • 21. Polymannuronic acid prevents dopaminergic neuronal loss via brain-gut-microbiota axis in Parkinson's disease model.
    Dong XL; Wang X; Liu F; Liu X; Du ZR; Li RW; Xue CH; Wong KH; Wong WT; Zhao Q; Tang QJ
    Int J Biol Macromol; 2020 Dec; 164():994-1005. PubMed ID: 32710966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson's disease via gut microbiota-GLP-1 pathway.
    Sun J; Li H; Jin Y; Yu J; Mao S; Su KP; Ling Z; Liu J
    Brain Behav Immun; 2021 Jan; 91():703-715. PubMed ID: 33148438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of gut microbiota in regulating gastrointestinal dysfunction and motor symptoms in a mouse model of Parkinson's disease.
    Bhattarai Y; Si J; Pu M; Ross OA; McLean PJ; Till L; Moor W; Grover M; Kandimalla KK; Margolis KG; Farrugia G; Kashyap PC
    Gut Microbes; 2021 Jan; 13(1):1866974. PubMed ID: 33459114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls.
    Unger MM; Spiegel J; Dillmann KU; Grundmann D; Philippeit H; Bürmann J; Faßbender K; Schwiertz A; Schäfer KH
    Parkinsonism Relat Disord; 2016 Nov; 32():66-72. PubMed ID: 27591074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vancomycin Pretreatment on MPTP-Induced Parkinson's Disease Mice Exerts Neuroprotection by Suppressing Inflammation Both in Brain and Gut.
    Cui C; Hong H; Shi Y; Zhou Y; Qiao CM; Zhao WJ; Zhao LP; Wu J; Quan W; Niu GY; Wu YB; Li CS; Cheng L; Hong Y; Shen YQ
    J Neuroimmune Pharmacol; 2023 Jun; 18(1-2):72-89. PubMed ID: 35091889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson's disease patients.
    Bedarf JR; Hildebrand F; Coelho LP; Sunagawa S; Bahram M; Goeser F; Bork P; Wüllner U
    Genome Med; 2017 Apr; 9(1):39. PubMed ID: 28449715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electroacupuncture may alleviate behavioral defects via modulation of gut microbiota in a mouse model of Parkinson's disease.
    Han QQ; Fu Y; Le JM; Pilot A; Cheng S; Chen PQ; Wu H; Wan GQ; Gu XF
    Acupunct Med; 2021 Oct; 39(5):501-511. PubMed ID: 33557583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring Fecal Microbiota Transplantation for Modulating Inflammation in Parkinson's Disease: A Review of Inflammatory Markers and Potential Effects.
    Sadowski K; Zając W; Milanowski Ł; Koziorowski D; Figura M
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered gut microbiota in patients with idiopathic Parkinson's disease: an age-sex matched case-control study.
    Babacan Yildiz G; Kayacan ZC; Karacan I; Sumbul B; Elibol B; Gelisin O; Akgul O
    Acta Neurol Belg; 2023 Jun; 123(3):999-1009. PubMed ID: 36719617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of device-assisted therapies on the gut microbiome in Parkinson's disease.
    Lubomski M; Xu X; Holmes AJ; Yang JYH; Sue CM; Davis RL
    J Neurol; 2022 Feb; 269(2):780-795. PubMed ID: 34128115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
    Lai F; Jiang R; Xie W; Liu X; Tang Y; Xiao H; Gao J; Jia Y; Bai Q
    Neurochem Res; 2018 Oct; 43(10):1986-1999. PubMed ID: 30171422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotection of Fasting Mimicking Diet on MPTP-Induced Parkinson's Disease Mice via Gut Microbiota and Metabolites.
    Zhou ZL; Jia XB; Sun MF; Zhu YL; Qiao CM; Zhang BP; Zhao LP; Yang Q; Cui C; Chen X; Shen YQ
    Neurotherapeutics; 2019 Jul; 16(3):741-760. PubMed ID: 30815845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut bacterial deamination of residual levodopa medication for Parkinson's disease.
    van Kessel SP; de Jong HR; Winkel SL; van Leeuwen SS; Nelemans SA; Permentier H; Keshavarzian A; El Aidy S
    BMC Biol; 2020 Oct; 18(1):137. PubMed ID: 33076930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-acetyl-L-leucine protects MPTP-treated Parkinson's disease mouse models by suppressing Desulfobacterota via the gut-brain axis.
    Xu Z; Lian C; Pan L; Lai W; Zhang F; Peng L; Zhou S; Zhao G; Yang X; Zhang G; Tan Z; Wang Y
    Brain Res Bull; 2023 Oct; 202():110729. PubMed ID: 37579888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The gut microbiome in Parkinson's disease: A culprit or a bystander?
    Keshavarzian A; Engen P; Bonvegna S; Cilia R
    Prog Brain Res; 2020; 252():357-450. PubMed ID: 32247371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Helicobacter hepaticus augmentation triggers Dopaminergic degeneration and motor disorders in mice with Parkinson's disease.
    Ahn EH; Liu X; Alam AM; Kang SS; Ye K
    Mol Psychiatry; 2023 Mar; 28(3):1337-1350. PubMed ID: 36543925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysbiosis of the gut microbiota and its effect on α-synuclein and prion protein misfolding: consequences for neurodegeneration.
    Mahbub NU; Islam MM; Hong ST; Chung HJ
    Front Cell Infect Microbiol; 2024; 14():1348279. PubMed ID: 38435303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
    Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
    Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label results.
    Fernandez HH; Standaert DG; Hauser RA; Lang AE; Fung VS; Klostermann F; Lew MF; Odin P; Steiger M; Yakupov EZ; Chouinard S; Suchowersky O; Dubow J; Hall CM; Chatamra K; Robieson WZ; Benesh JA; Espay AJ
    Mov Disord; 2015 Apr; 30(4):500-9. PubMed ID: 25545465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut brain axis: an insight into microbiota role in Parkinson's disease.
    Moustafa SA; Mohamed S; Dawood A; Azar J; Elmorsy E; Rizk NAM; Salama M
    Metab Brain Dis; 2021 Oct; 36(7):1545-1557. PubMed ID: 34370175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.